Abstract:OBJECTIVE:To explore the therapeutic efficacy of double suicide gene system driven by carcinoembryonic antigen (CEA) promoter (Cp-CDglyTK) on colorectal carcinoma xenograft in nude mice. METHODS:The plasmid pcDNA3.1(-)Cp-CDglyTK was transfected into the CEA-positive SW480 and CEA-negative HeLa cells respectively. The expression of suicide gene was detected by RT-PCR. And the transfected cells were treated with 5-fluorocytosine (5-FC) and ganciclovir (GCV) at different concentrations and the cell-killing and bystander effects assayed by methyl thiazolyl tetrazolium (MTT). By a transplantation of cultivated cells, SW480 or HeLa cell lines were injected subcutaneously into right axillary of nude mice to establish 96 SW480 and 72 HeLa tumor animal models. Nude mice were completely randomized with statistical software according to tumor volume. For prodrug therapy, 48 SW480-bearing mice were divided equally into 4 groups of I-IV. At the same time, 48 HeLa-bearing mice were divided equally into 4 groups of V-VIII. Groups I & V received an intratumoral injection of PBS, groups II & VIGCV and 5-FC intratumorally, groups III & VII PBS intraperitoneally and groups IV & VIII GCV and 5-FC intraperitoneally. Forty-eight SW480-bearing mice were divided equally into 4 groups of IX∼XII and 24 Hela-bearing ones into groups of & in therapy experiment by suicide gene plus prodrug. Six groups received an intratumoral injection of liposome Lipofectamine and plasmid CP-CDglyTK and then an intraperitoneal injection of drug. The groups of IX and received an injection of PBS, group X GCV, group XI 5-FC and groups XII & GCV and 5-FC. The observation parameters included tumor bulk, tumor weight, survival time and treatment effect in each group. RESULTS:SW480 cells transfected by plasmid pcDNA3.1(-)Cp- CDglyTK expressed CDglyTK gene. The inhibition rates of GCV and 5-FC were significantly higher than those of HeLa cells (59.87% ± 0.21% vs 9.90% ± 0.09%, P < 0.01). And higher inhibition rates and stronger bystander effect existed in double versus single produg (all P < 0.05). Tumor size, final tumor weight and survival time of nude mice in groups ofII, IV, VI & VIII had no significant difference with groups ofI, III, V & VII (all P < 0.05). Final tumor size and weight of group XII was significantly smaller than those of groups of IX, X and XI ((150.0 ± 3.2) vs (522.5 ± 1.9) and (256.8 ± 10.4) and (260.7 ± 2.2) mm(3), (54.1 ± 10.4) vs (682.0 ± 12.0) and (251.8 ± 15.1) and (271.6 ± 17.7) mg, all P < 0.05). Meanwhile, the tumor inhibition rate and survival time of group XII(92.1% and (25.7 ± 0.8)d) were significant higher and longer than group X (63.1% and (21.8 ± 0.5) d) and group XI (60.2% and (18.0 ± 0.9) d) (all P < 0.05). However, no significant difference existed in tumor size, final tumor weight and survival time between groups and (all P > 0.05). The inhibition rate of group was merely 0.9%. CONCLUSION:CDglyTK double suicide gene system driven by CEA promoter may inhibit CEA positive colorectal cancer xenograft in prodrug-treated nude mice.

Antitumor Effects of Cytosine Deaminase and Thymidine Kinase Fusion Suicide Gene under the Control of Mdr1 Promoter in Mdr1 Positive Leukemia Cells

Study on the targeted killing effects of CD-TK double suicide genes driven by mdr1 promoter on mul-tidrug-resistant K562 cell line in vitro

Antibody-directed Double Suicide Gene Therapy Targeting of MUC1- Positive Leukemia Cells in Vitro and in Vivo.

Targeted Killing Effects of Double Suicide Genes Controlled by the MDR1 Promoter on C6/ADR Cells

Reversal of Multidrug Resistance by Magnetic Fe3o4 Nanoparticle Copolymerizating Daunorubicin and Mdr1 Shrna Expression Vector in Leukemia Cells

Killing Effects of Cytosine Deaminase and HSV-tk Double Suicide Genes on K562 Cells Mediated by Retrovirus Vector

Construction of expressive vector containing double suicide genes controlled by MDR1 promoter and its expression in K562/A02 cell

Effect of D, L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol and tetrandrine on the reversion of multidrug resistance in K562/A02 cells.

In Vitro Study of the Effect of Cyclosporine A, Tetrandrine and Their Combination on the Reversion of Multidrug Resistance in Leukemia Cell Line.

The Targeted Gene (KDRP-CD/TK) Therapy of Breast Cancer Mediated by SonoVue and Ultrasound Irradiation in Vitro

Construction of Double Suicide Genes System Controlled by MDR1 Promoter with Targeted Expression in Drug-Resistant Glioma Cells

Cytokine-induced Killer Cells Showing Multidrug Resistance and Remaining Cytotoxic Activity to Tumor Cells after Transfected with Mdr1 Cdna

Experimental Study on the Transcriptional Targeting Gene Therapy of Double Suicide Gene Driven by KDR Promotor in Lung Cancer

Retro viral mediated efficient transfer andexpression of multiple drug resistance gene to human leukemic cells

[Cytosine Deaminase and Thymidine Kinase Double Suicide Gene System Driven by Carcinoembryonic Antigen Promoter for the Treatment of Colorectal Carcinoma Xenograft in Nude Mice].

Enhanced antitumor effects of suicide gene therapy by simultaneous transfer of GM-CSF gene in leukemia-bearing mice

[Nf-Kappab Regulating Expression of Mdr1 Gene and P-gp to Reverse Drug-Resistance in Leukemic Cells].

Antitumor Efficiency of the Cytosine Deaminase/5-Fluorocytosine Suicide Gene Therapy System on Malignant Gliomas: an in Vivo Study.

Sensitization and Apoptosis Augmentation of K562/ADM Cells by Anti-Multidrug Resistance Gene Peptide Nucleic Acid and Antisense Oligodeoxyribonucleotide.

Double Suicide Genes Driven by Kinase Domain Insert Containing Receptor Promoter Selectively Kill Human Lung Cancer Cells

Reversal of Multidrug Resistance by MDR1 Shrna Expression Vector in Human Leukemia K562/A02cells